Latest Advances

  • Condition: Gastroesophageal Reflux Disease
  • Journal: European review for medical and pharmacological sciences
  • Treatment Used: Omeprazole
  • Number of Patients: 22
  • Published —
In this study, researchers evaluated the outcomes of using omeprazole for the treatment of gastroesophageal reflux disease in children with cystic fibrosis.
  • Condition: Persistent Throat Symptoms
  • Journal: Health technology assessment (Winchester, England)
  • Treatment Used: Lansoprazole
  • Number of Patients: 346
  • Published —
The aim of this study was to assess the value of proton pump inhibitor therapy with lansoprazole in patients with persistent throat symptoms.
  • Condition: Gastroesophageal Reflux Disease
  • Journal: JAMA
  • Treatment Used: Lifestyle Modification, Proton Pump Inhibitor Medication, and Laparoscopic Fundoplication
  • Number of Patients: 0
  • Published —
The study researched the outcomes of treatment for gastroesophageal reflux disease.
  • Condition: Chronic Biliar Antral Reflux-Gastritis
  • Journal: Terapevticheskii arkhiv
  • Treatment Used: Grinterol
  • Number of Patients: 50
  • Published —
This study tested the safety and efficacy of using grinterol (ursodexic acid) to treat patients with chronic biliar antral reflux-gastritis.
  • Condition: Gastroesophageal Reflux Disease
  • Journal: Drugs of today (Barcelona, Spain : 1998)
  • Treatment Used: Tegoprazan
  • Number of Patients: NULL
  • Published —
The study researched the effects of tegoprazan in patients with gastroesophageal reflux disease.
  • Condition: Paraesophageal Hernia
  • Journal: JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • Treatment Used: Laparoscopic Gastropexy
  • Number of Patients: 26
  • Published —
This study tested the safety and efficacy of using laparoscopic gastropexy to treat patients with paraesophageal hernias.
  • Condition: Gastroesophageal Reflux Disease (GERD)
  • Journal: European review for medical and pharmacological sciences
  • Treatment Used: Alginate Formulations vs. Proton Pump Inhibitors (PPIs)
  • Number of Patients: 0
  • Published —
This review of the literature compared the safety and effectiveness of an alginate-based formulation versus proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD).
  • Condition: Infant Gastroesophageal Reflux Disease
  • Journal: Clinical and translational gastroenterology
  • Treatment Used: Feeding Modifications with Acid Suppression
  • Number of Patients: 49
  • Published —
This study investigated the use of feeding modifications with acid suppression to treat patients with infant gastroesophageal reflux disease.
  • Condition: Moderate and Severe Obstructive Sleep Apnea
  • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • Treatment Used: Noninvasive Positive-pressure Ventilation
  • Number of Patients: 23
  • Published —
In this study, researchers evaluated the outcomes of noninvasive positive-pressure ventilation for the treatment of reflux in patients with moderate and severe obstructive sleep apnea.
  • Condition: Laryngospharyngeal Reflux Disease
  • Journal: Journal of Nepal Health Research Council
  • Treatment Used: Proton Pump Inhibitor Monotherapy Versus Triple Therapy
  • Number of Patients: 704
  • Published —
This study compared two regimens (proton pump inhibitor monotherapy versus triple therapy) on the outcome of laryngopharyngeal reflux disease.
  • Condition: Proximal Gastric Cancer
  • Journal: PloS one
  • Treatment Used: Laparoscopy-Assisted Proximal Gastrectomy with or without Esophagogastrostomy
  • Number of Patients: 36
  • Published —
This study compared the clinical outcome of using laparoscopy-assisted proximal gastrectomy with or without esophagogastrostomy to treat patients with proximal gastric cancer.
  • Condition: Gastroesophageal Reflux Disease
  • Journal: Medicine
  • Treatment Used: DA-5204 and PPI Combination Therapy
  • Number of Patients: 59
  • Published —
In this study, researchers evaluated the outcomes of using DA-5204 and PPI combination therapy for the treatment of gastroesophageal reflux disease.
Showing 1-12 of 198